Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis. [electronic resource]
Producer: 19930305Description: 196-201 p. digitalISSN:- 0272-6386
- Adult
- Antilymphocyte Serum -- therapeutic use
- Cadaver
- Cohort Studies
- Cytomegalovirus Infections -- epidemiology
- Female
- Graft Rejection -- prevention & control
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Kidney Transplantation -- immunology
- Male
- Multivariate Analysis
- Muromonab-CD3 -- therapeutic use
- Prospective Studies
- Risk Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.